Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
- DOI
- 10.1001/jamaoncol.2023.2934
- Published
- 2023 Oct 1
- Container
- JAMA oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamaoncol.2023.2934,
title = {Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.},
author = {Gulati S and Hsu CY and Shah S and Shah PK and Zon R and Alsamarai S and Awosika J and El-Bakouny Z and Bashir B and Beeghly A and Berg S and de-la-Rosa-Martinez D and Doroshow DB and Egan PC and Fein J and Flora DB and Friese CR and Fromowitz A and Griffiths EA and Hwang C and Jani C and Joshi M and Khan H and Klein EJ and Heater NK and Koshkin VS and Kwon DH and Labaki C and Latif T and McKay RR and Nagaraj G and Nakasone ES and Nonato T and Polimera HV and Puc M and Razavi P and Ruiz-Garcia E and Saliby RM and Shastri A and Singh SRK and Tagalakis V and Vilar-Compte D and Weissmann LB and Wilkins CR and Wise-Draper TM and Wotman MT and Yoon JJ and Mishra S and Grivas P and Shyr Y and Warner JL and Connors JM and Shah DP and Rosovsky RP and COVID-19 and Cancer Consortium},
year = {2023},
journal = {JAMA oncology},
doi = {10.1001/jamaoncol.2023.2934},
url = {https://doi.org/10.1001/jamaoncol.2023.2934}
}RIS
TY - JOUR TI - Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. AU - Gulati S AU - Hsu CY AU - Shah S AU - Shah PK AU - Zon R AU - Alsamarai S AU - Awosika J AU - El-Bakouny Z AU - Bashir B AU - Beeghly A AU - Berg S AU - de-la-Rosa-Martinez D AU - Doroshow DB AU - Egan PC AU - Fein J AU - Flora DB AU - Friese CR AU - Fromowitz A AU - Griffiths EA AU - Hwang C AU - Jani C AU - Joshi M AU - Khan H AU - Klein EJ AU - Heater NK AU - Koshkin VS AU - Kwon DH AU - Labaki C AU - Latif T AU - McKay RR AU - Nagaraj G AU - Nakasone ES AU - Nonato T AU - Polimera HV AU - Puc M AU - Razavi P AU - Ruiz-Garcia E AU - Saliby RM AU - Shastri A AU - Singh SRK AU - Tagalakis V AU - Vilar-Compte D AU - Weissmann LB AU - Wilkins CR AU - Wise-Draper TM AU - Wotman MT AU - Yoon JJ AU - Mishra S AU - Grivas P AU - Shyr Y AU - Warner JL AU - Connors JM AU - Shah DP AU - Rosovsky RP AU - COVID-19 and Cancer Consortium PY - 2023 JO - JAMA oncology DO - 10.1001/jamaoncol.2023.2934 UR - https://doi.org/10.1001/jamaoncol.2023.2934 ER -
APA
S, G., CY, H., S, S., PK, S., R, Z., S, A., J, A., Z, E., B, B., A, B., S, B., D, D., DB, D., PC, E., J, F., DB, F., CR, F., A, F., EA, G., C, H., C, J., M, J., H, K., EJ, K., NK, H., VS, K., DH, K., C, L., T, L., RR, M., G, N., ES, N., T, N., HV, P., M, P., P, R., E, R., RM, S., A, S., SRK, S., V, T., D, V., LB, W., CR, W., TM, W., MT, W., JJ, Y., S, M., P, G., Y, S., JL, W., JM, C., DP, S., RP, R., & Consortium, C. A. C. (2023). Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2023.2934
Source records
- pubmed · retrieved 2026-09-26T18:20:15.502Z